Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nocturnal Closed-Loop Control Using An ePID (Enhanced Proportional Integral Derivative) Algorithm On An Android Platform With Remote Monitoring In A Closely Monitored Camp Setting: The OCL Camp Study

NCT01881009 is registered in ClinicalTrials.gov with Bruce A. Buckingham as lead sponsor.

NCT NCT01881009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01881009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nocturnal Closed-Loop Control Using An ePID (Enhanced Proportional Integral Derivative) Algorithm On An Android Platform With Remote Monitoring In A Closely Monitored Camp Setting: The OCL Camp Study
Lead sponsor
Bruce A. Buckingham
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2013
Completion date
August 3, 2013
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diabetes, diabetes, mellitus, type 1, juvenile-onset diabetes, type 1 diabetes mellitus